Market Tracker

03/27 7:39am ET

Impax Laboratories Inc (NASDAQ:IPXL)

44.87
Delayed Data
As of Mar 26
 +0.42 / +0.94%
Today’s Change
22.12
Today|||52-Week Range
47.70
+41.64%
Year-to-Date

Today’s Trading

Previous close44.45
Today’s open44.30
Day’s range-- - --
Volume421,738
Average volume (3 months)669,600
Market cap$3.2B
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+13.19%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+16.53%
P/E ratio55.2
Price/Sales3.62
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.83-2.66%
NBIXNeurocrine Bioscienc...+0.96+2.64%
HZNPHorizon Pharma PLC+0.53+2.55%
MYGNMyriad Genetics Inc-0.65-1.78%
Data as of 03/26/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.16
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts